Intuitive Announces U.S. Food & Drug Administration Clears Its Latest Innovation in Advanced Energy Instrumentation for Use with Its Multiport Da Vinci Systems
ISRG
Published on 07/10/2025 at 10:35
Intuitive announced that the U.S. Food & Drug Administration (FDA) has cleared its latest innovation in advanced energy instrumentation for use with its multicort da Vinci systems. Vessel Sealer Curved is a fully wristed, advanced bipolar electrosurgical instrument designed to seal, cut, grasp, and dissect tissue. It is the first of Intuitive's advanced energy instruments to receive FDA clearance for the transection of lymphatic vessels. Vessel Sealer Curved offers enhanced multifunctionality and precision via its slim, curved jaw designed to follow the natural contours of anatomy, helping improve visibility and control especially in tight spaces and around critical structures.
The instrument's mechanical blade cuts closer to the tip, offering versatility as a sector. The FDA cleared Vessel Sealer Curved for grasping and blunt dissection of tissue, as well as bipolar coagulation and mechanical transection of blood vessels (veins and arteries) up to 7mm in diameter, lymphatic vessels, and tissue bundles that fit within the instrument's jaws. Vessel Sealer Curved are not indicated for tubal sterilization or tubal coagulation for sterilization procedures and should not be used for these procedures.
2025 marks Intuitive's 30th year developing robotic-assisted technology with the goal of improving patient outcomes, improving patient and care team experience, increasing access to minimally invasive care, and lowering the total cost to treat. In Intuitive's first three decades, surgeons performed nearly 17 million da Vinci procedures, and nearly 90,000 surgeons have been trained to use Intuitive's systems.